Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Class A ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
17,244,009
-
Total 13F shares
-
15,281,948
-
Share change
-
+1,322,260
-
Total reported value
-
$155,786,911
-
Price per share
-
$10.35
-
Number of holders
-
41
-
Value change
-
+$15,103,754
-
Number of buys
-
9
-
Number of sells
-
12
Institutional Holders of Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share (TDAC) as of Q3 2025
As of 30 Sep 2025,
Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share (TDAC) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,281,948 shares.
The largest 10 holders included
WOLVERINE ASSET MANAGEMENT LLC, Magnetar Financial LLC, AQR Arbitrage LLC, LMR Partners LLP, Hudson Bay Capital Management LP, First Trust Capital Management L.P., TENOR CAPITAL MANAGEMENT Co., L.P., Karpus Management, Inc., Linden Advisors LP, and Polar Asset Management Partners Inc..
This page lists
41
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.